Global

Infectious Diseases Experts

Miguel Pineda

ARUK Research Fellow
Department of Infection, Immunity & Inflammation
University of Glasgow
United Kingdom

Biography

Miguel Pineda is currently working as a ARUK Research Fellow in the Department of Infection, Immunity & Inflammation

Research Interest

In health, synovial fibroblasts provide structural and nutritional support within the joint, but increasingly are recognized to serve as critical regulators of the inflammatory microenvironment in disease. Thus, despite fibroblasts are non-immune cells of stromal origin, they play a critical role in the perpetuation of inflammatory rheumatoid arthritis (RA). Why do synovial fibroblasts adopt an inflammatory phenotype in RA? Functional glycomics, an exciting, emerging discipline focused on defining the structures and functional roles of glycans in biological systems, can offer new answers to this old question because glycans and complementary glycan-binding proteins are essential components in the language of cell-cell interactions in immunity. My aim is to understand how the biological information contained in surface glycans controls the inflammatory response of synovial fibroblasts in RA. Ultimately, understanding changes in cell glycosylation in disease should provide further insight into the mechanisms underlying fibroblast-dependent inflammation and may confer novel stratified therapeutic approaches by virtue of discrete glycomic signatures.

Publications

  • Laté de Laté, P., Pineda, M., Harnett, M., Harnett, W., Besteiro, S. and Langsley, G. (2017) Apicomplexan autophagy and modulation of autophagy in parasite-infected host cells. Biomedical Journal, 40(1), pp. 23-30.

  • Harnett, M. M., Pineda, M. A., Latré de Laté, P., Eason, R. J., Besteiro, S., Harnett, W. and Langsley, G. (2017) From Christian de Duve to Yoshinori Ohsumi: more to autophagy than just dining at home. Biomedical Journal, 40(1), pp. 9-22.

  • Lumb, F. E., Doonan, J., Bell, K. S., Pineda, M. A., Corbet, M., Suckling, C. J., Harnett, M. M. and Harnett, W. (2017) Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62. Scientific Reports, 7(1), 1704.

Global Experts from United Kingdom

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America